Skip to main content

Table 5 Route of administration for non-prescribed use

From: Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities

Route of administration

Methadone (361)

Buprenorphine (330)

Buprenorphine/naloxone (208)

Sublingually

NV

79.7%

85.6%

Snorted

NV

70.6%%

51.0%

Injected

47.4%

40.9%

15.4%

Orally

100.0%

NA

NA

  1. NA not asked, NV non-viable means of consumption
Back to article page

Harm Reduction Journal

ISSN: 1477-7517